<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T13:01:54Z</responseDate>
  <request identifier="oai:figshare.com:article/34016959" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34016959</identifier>
        <datestamp>2026-09-28T17:38:45Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Characteristics of studies reported the prevalence of Pre-XDR and XDR-TB among MDR-TB cases in Ethiopia.&lt;/p&gt;</dc:title>
          <dc:creator>Muluneh Assefa (12029676)</dc:creator>
          <dc:creator>Mitkie Tigabie (16274405)</dc:creator>
          <dc:creator>Abebaw Setegn (19485456)</dc:creator>
          <dc:creator>Yenesew Mihret Wondmagegn (19485459)</dc:creator>
          <dc:creator>Azanaw Amare (6589409)</dc:creator>
          <dc:creator>Getu Girmay (19068230)</dc:creator>
          <dc:creator>Sirak Biset (12400926)</dc:creator>
          <dc:creator>Wesam Taher Almagharbeh (21604373)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>valuable evidence synthesis</dc:subject>
          <dc:subject>preferred reporting items</dc:subject>
          <dc:subject>egger &amp;# 8217</dc:subject>
          <dc:subject>2019 &amp;# 8211</dc:subject>
          <dc:subject>2005 &amp;# 8211</dc:subject>
          <dc:subject>relatively higher prevalence</dc:subject>
          <dc:subject>analysis &lt;/ p</dc:subject>
          <dc:subject>3 %, respectively</dc:subject>
          <dc:subject>overall pooled prevalence</dc:subject>
          <dc:subject>tb across studies</dc:subject>
          <dc:subject>resistant tuberculosis cases</dc:subject>
          <dc:subject>single study conducted</dc:subject>
          <dc:subject>tb among mdr</dc:subject>
          <dc:subject>single studies</dc:subject>
          <dc:subject>subgroup analysis</dc:subject>
          <dc:subject>resistant tuberculosis</dc:subject>
          <dc:subject>pooled prevalence</dc:subject>
          <dc:subject>pooled proportions</dc:subject>
          <dc:subject>significant prevalence</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>tukey transformation</dc:subject>
          <dc:subject>systematic reviews</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>study year</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>strengthened surveillance</dc:subject>
          <dc:subject>relevant articles</dc:subject>
          <dc:subject>oromia reported</dc:subject>
          <dc:subject>local strains</dc:subject>
          <dc:subject>i2 statistic</dc:subject>
          <dc:subject>funnel plot</dc:subject>
          <dc:subject>forest plot</dc:subject>
          <dc:subject>extracted data</dc:subject>
          <dc:subject>effects model</dc:subject>
          <dc:subject>effect size</dc:subject>
          <dc:subject>confidence interval</dc:subject>
          <dc:subject>computed using</dc:subject>
          <dc:subject>challenging problems</dc:subject>
          <dc:subject>better management</dc:subject>
          <dc:subject>become one</dc:subject>
          <dc:subject>addis ababa</dc:subject>
          <dc:subject>69 %)</dc:subject>
          <dc:subject>656 new</dc:subject>
          <dc:subject>07 %).</dc:subject>
          <dc:description>&lt;p&gt;Characteristics of studies reported the prevalence of Pre-XDR and XDR-TB among MDR-TB cases in Ethiopia.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T18:02:49Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pntd.0014744.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Characteristics_of_studies_reported_the_prevalence_of_Pre-XDR_and_XDR-TB_among_MDR-TB_cases_in_Ethiopia_p_/34016959</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
